###begin article-title 0
###xml 49 54 49 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Forced expression of the cell cycle inhibitor p57Kip2 in cardiomyocytes attenuates ischemia-reperfusion injury in the mouse heart
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 244 247 244 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 247 250 247 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 247 252 247 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 396 401 396 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 537 540 537 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 540 543 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 540 545 540 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 603 612 603 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 687 690 687 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 687 692 687 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 821 834 821 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 834 835 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 834 837 834 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 857 862 857 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 938 943 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlc2v</italic>
###xml 814 819 <span type="species:ncbi:10090">mouse</span>
Myocardial hypoxic-ischemic injury is the cause of significant morbidity and mortality worldwide. The cardiomyocyte response to hypoxic-ischemic injury is known to include changes in cell cycle regulators. The cyclin-dependent kinase inhibitor p57Kip2 is involved in cell cycle control, differentiation, stress signaling and apoptosis. In contrast to other cyclin-dependent kinase inhibitors, p57Kip2 expression diminishes during postnatal life and is reactivated in the adult heart under conditions of cardiac stress. Overexpression of p57Kip2 has been previously shown to prevent apoptotic cell death in vitro by inhibiting stress-activated kinases. Therefore, we hypothesized that p57Kip2 has a protective role in cardiomyocytes under hypoxic conditions. To investigate this hypothesis, we created a transgenic mouse (R26loxpTA-p57k/+) that expresses p57Kip2 specifically in cardiac tissue under the ventricular cardiomyocyte promoter Mlc2v.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 59 64 59 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 377 380 377 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max</sub>
###xml 587 595 587 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 645 648 645 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 648 651 648 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 648 653 648 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 885 886 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
Transgenic mice with cardiac specific overexpression of p57Kip2 are viable, fertile and normally active and their hearts are morphologically indistinguishable from the control hearts and have similar heart weight/body weight ratio. The baseline functional parameters, including left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LVEDP), LVdp/dtmax, heart rate (HR) and rate pressure product (RPR) were not significantly different between the different groups as assessed by the Langendorff perfused heart preparation. However, after subjecting the heart ex vivo to 30 minutes of ischemia-reperfusion injury, the p57Kip2 overexpressing hearts demonstrated preserved cardiac function compared to control mice with higher left ventricular developed pressure (63 +/- 15 vs 30 +/- 6 mmHg, p = 0.05), rate pressure product (22.8 +/- 4.86 vs 10.4 +/- 2.1 x 103bpm x mmHg, p < 0.05) and coronary flow (3.5 +/- 0.5 vs 2.38 +/- 0.24 ml/min, p <0.05).
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 56 61 56 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 195 200 <span type="species:ncbi:10090">mouse</span>
These data suggest that forced cardiac expression of p57Kip2 does not affect myocardial growth, differentiation and baseline function but attenuates injury from ischemia-reperfusion in the adult mouse heart.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
Ischemic heart disease is the leading cause of morbidity and mortality in the industrialized world, but the development of effective therapy has been hampered by the lack of mechanistic insights into the physiological response of the heart to hypoxic stress. Adult cardiomyocytes respond to hypoxic stress by reverting to genetic programs associated with embryonic cardiac development, collectively referred to as "the fetal gene program" [1]. One of the most critical factors controlling heart growth and development is intrauterine oxygen availability [2,3]. Embryonic cardiac development occurs in an environment of low oxygen tension and hypoxia regulates several stress-related pathways affecting cellular proliferation, differentiation and death. While the low oxygen tension at this stage of development is "physiologic", the genes whose expression is modulated by differences in oxygen tension are adapted to the ambient levels of oxygen during this period. Recapitulation of this developmental program may be a physiologic adaptation that allows the ischemic heart to respond to hypoxia.
###end p 9
###begin p 10
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 577 582 577 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ink4a</sup>
###xml 587 592 587 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ink4b</sup>
###xml 597 602 597 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Ink4c</sup>
###xml 607 610 607 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ARF</sup>
###xml 677 681 677 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cip1</sup>
###xml 686 690 686 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip1</sup>
###xml 699 703 699 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 730 731 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 833 834 833 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 865 870 865 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 931 934 931 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 934 939 934 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1039 1041 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1064 1067 1064 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 1067 1075 1067 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2-/- </sup>
###xml 1165 1174 1165 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in utero </italic>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1293 1296 1293 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 1296 1301 1296 1301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1362 1367 1362 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1454 1456 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1476 1481 1476 1481 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1578 1580 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1634 1639 1634 1639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cip1 </sup>
###xml 1646 1651 1646 1651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip1 </sup>
###xml 1659 1661 1659 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1075 1079 <span type="species:ncbi:10090">mice</span>
###xml 1280 1285 <span type="species:ncbi:10090">mouse</span>
###xml 1514 1519 <span type="species:ncbi:9606">human</span>
Heart cells divide during development and then exit the cell cycle as they undergo terminal differentiation [4,5]. This lack of proliferative capacity poses a challenge for hearts that undergo ischemic injury as they loose cardiac mass and terminal heart failure frequently results. During development, cardiomyocytes proliferate extensively. Cells are driven through the cell cycle by a complex of two classes of proteins, cyclins and cyclin dependent kinases (CDKs). This complex is regulated by two families of cyclin-dependent kinase inhibitors (CKIs). The INK4 family (p16Ink4a, p15Ink4b, p18Ink4c, p19ARF) specifically inhibit CDK4 and CDK6, while the CIP/KIP family (p21Cip1, p27Kip1, and p57Kip2) inhibit all G1/S CDKs [6,7]. The CKIs are implicated in cell cycle exit and terminal differentiation in a number of cell types [8-10]. Of all the CKIs, only p57Kip2 has been shown to be essential for embryonic development, as p57Kip2 null mice display significant congenital defects such as cleft palate, omphalocele and short limbs [11-13]. In addition, the p57Kip2-/- mice exhibit increased apoptosis in many tissues, including the heart. They typically die in utero or soon after birth due to aspiration and respiratory insufficiency from the cleft palate [12,13]. In the mouse heart, p57Kip2 message is up-regulated during mid-gestation [12,14]. The p57Kip2 protein levels peak during late gestation, and then disappear during early fetal life [15]. Low levels of p57Kip2 protein are present in the adult human heart, which then increase during terminal heart failure [16]. By contrast, there is a concomitant decrease in p21Cip1 and p27Kip1 levels [16].
###end p 10
###begin p 11
###xml 41 46 41 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 96 101 96 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 231 236 231 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 313 318 313 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 521 526 521 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cip1 </sup>
###xml 533 538 533 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip1 </sup>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 714 719 714 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 952 957 952 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cip1 </sup>
###xml 964 969 964 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip1 </sup>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1021 1026 1021 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1178 1183 1178 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 565 568 <span type="species:ncbi:10116">rat</span>
Apart from inhibiting the cell cycle, p57Kip2 has additional roles in the cell. For example, p57Kip2 modulates stress activated signaling by functioning as an endogenous inhibitor of c-Jun kinase (JNK/SAPK), as the QT domain of p57Kip2 binds and inhibits the JNK/SAPK pro-apoptotic activity [17]. In addition, p57Kip2 is up-regulated at early time points of hypoxia [18], indicating it is within the early wave of hypoxia-responsive genes rather than being secondarily induced. Previous studies have demonstrated that p21Cip1 and p27Kip1 overexpression in cultured rat cardiomyocytes protects the cells from hypoxia-induced apoptosis, and this protection appears to be independent of CKI activity [19]. Because p57Kip2 is differentially regulated from the two other CIP/KIP family members during hypoxic stress, it is plausible that it possesses similar cardioprotective properties in this setting and compensates for the observed downregulation of p21Cip1 and p27Kip1 in the stressed heart [20]. The possibility that p57Kip2 has a previously unrecognized role in cardiac biology related to protection from hypoxic-ischemic injury has not been examined. We hypothesized that p57Kip2 protects cardiomyocytes under conditions of limited oxygen supply as occurs during embryonic cardiac development and in ischemic injury of the adult heart.
###end p 11
###begin p 12
###xml 57 70 57 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 129 134 129 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 218 228 218 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlc2v- Cre</italic>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 228 232 228 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 281 286 281 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 389 392 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 389 394 389 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 486 491 486 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
To evaluate this hypothesis, we generated a mouse model (R26loxpTA-p57k/+) that allows cre-inducible functional expression of p57Kip2 in a tissue-specific fashion. We used this transgenic model in combination with the Mlc2v- Crek/+ transgenic mouse to force myocardial specific p57Kip2 expression in the embryonic and adult heart [21] and we show that myocardial specific expression of p57Kip2 attenuates hypoxic-ischemic injury in the adult mouse heart. These findings suggest that p57Kip2 may represent a developmentally regulated protein aiming to protect cardiomyocytes under conditions of limited oxygen supply during development and in pathologic ischemic conditions of adulthood.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 38 43 38 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
Cardiac specific overexpression of p57Kip2 does not affect heart development or cardiomyocyte proliferation
###end title 14
###begin p 15
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 13 18 13 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 98 101 98 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tpA</italic>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 141 144 141 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 141 146 141 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 221 234 221 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 234 237 234 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 317 327 317 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlc2v- Cre</italic>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlc2v</italic>
###xml 557 560 557 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 560 565 560 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 637 650 637 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 650 651 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 650 653 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 653 663 653 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/Mlc2v-Cre</italic>
###xml 663 664 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 663 666 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 666 668 666 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">) </italic>
###xml 937 938 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 953 966 953 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 966 967 966 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 966 969 966 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 969 979 969 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/Mlc2v-Cre</italic>
###xml 979 980 979 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 979 983 979 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 1097 1100 1097 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 1100 1103 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 1100 1105 1100 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 1239 1242 1239 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 1242 1245 1242 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 1242 1247 1242 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 1377 1379 1377 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1381 1383 1381 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 204 219 <span type="species:ncbi:10090">transgenic mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 331 346 <span type="species:ncbi:10090">transgenic mice</span>
###xml 718 733 <span type="species:ncbi:10090">transgenic mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
Since the p57Kip2 cDNA is preceded by a loxP-flanked strong transcriptional termination sequence (tpA), in the absence of cre-recombinase p57Kip2 transcription is terminated prematurely and the generated transgenic mice (R26loxpTA-p57k/+) were phenotypically normal as expected. When these mice were crossed with the Mlc2v- Crek/+ transgenic mice that express cre-recombinase under the transcriptional control of the myosin light chain-2 ventricular (mlc2v) promoter, the cre-mediated excision of the floxed termination sequence led to forced expression of p57Kip2 in ventricular cardiomyocytes. Fifty-three double heterozygous animals (R26loxpTA-p57k/+/Mlc2v-Crek/+) from these crosses have been analyzed. The double transgenic mice developed normally and no defects in embryos or adults were observed. Litter sizes and fertility were similar to those of control mice and offspring were produced in the expected Mendelian ratios (Table 1). None of the R26loxpTA-p57k/+/Mlc2v-Crek/+ mice were prone to early lethality over 2 years of observation suggesting that cardiac specific overexpression of p57Kip2 is well tolerated from the very early stages of myocardial differentiation. Ventricular tissue-specific cre-recombination that allows p57Kip2 over-expression in cardiomyocytes of the compound heterozygous offspring could be detected by PCR as shown in the diagram (Figure 1A, 1C).
###end p 15
###begin p 16
###xml 46 59 46 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxp-TAp57</italic>
###xml 59 60 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 62 72 62 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-cre</italic>
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
Genotype analysis of offspring resulting from R26loxp-TAp57k/+;Mlc2v-crek/+crosses.
###end p 16
###begin p 17
###xml 4 17 4 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxp-TAp57</italic>
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 20 30 20 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-cre</italic>
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 130 135 130 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">KIP2 </sup>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26p57 </italic>
###xml 210 223 210 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxp-TAp57</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/<italic>k</italic></sup>
###xml 226 236 226 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-cre</italic>
###xml 236 237 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 236 239 236 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
The R26loxp-TAp57k/+;Mlc2v-crek/+ genotype is represented in the expected Mendelian ratio in the offspring. However, mice with p57KIP2 cardiac-specific overexpression that are homozygous for the R26p57 allele (R26loxp-TAp57k/k;Mlc2v-crek/+) are significantly under-represented in the offspring (p < 0.01 by Chi-square and n = 203)
###end p 17
###begin p 18
###xml 60 65 60 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Creation of a transgenic mouse with forced expression of p57<sup>Kip2 </sup>in a cre dependent manner</bold>
###xml 92 96 92 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre </italic>
###xml 274 278 274 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 327 331 327 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre-</italic>
###xml 490 494 490 494 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 547 552 547 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre </italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre </italic>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Creation of a transgenic mouse with forced expression of p57Kip2 in a cre dependent manner. (A) Recombination scheme displaying the structure of the targeting vector, genomic R26 locus, targeted locus after homologous recombination and recombined locus after cre activation (B) PCR genotype analysis of tail genomic DNA (gDNA) (C) PCR analysis shows that cre-induced recombination is restricted to the heart, and occurs only in the presence of cre recombinase. T= tail gDNA, H = heart gDNA (D) RT-PCR analysis demonstrates robust expression of p57Kip2 message in adult transgenic hearts in the presence of cre recombinase, compared to barely detectable levels in the absence of cre recombinase.
###end p 18
###begin p 19
###xml 15 20 15 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 119 132 119 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 205 218 205 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 221 231 221 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">/Mlc2v-Cre</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 231 234 231 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">) </italic>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 292 297 292 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 473 476 473 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 476 479 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 476 481 476 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 771 781 771 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlc2v-Cre </italic>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 908 911 908 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 911 914 911 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 911 916 911 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 965 966 965 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 967 969 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1190 1195 1190 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1262 1275 1262 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 1275 1276 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1275 1278 1275 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 1278 1288 1278 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-Cre</italic>
###xml 1288 1289 1288 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 1288 1292 1288 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 1375 1379 1375 1379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 1465 1466 1465 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1491 1496 1491 1496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1587 1589 1587 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2F</xref>
###xml 1591 1593 1591 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 1694 1699 1694 1699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1776 1781 1776 1781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 656 661 <span type="species:ncbi:10090">mouse</span>
###xml 781 786 <span type="species:ncbi:10090">mouse</span>
###xml 855 870 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1292 1307 <span type="species:ncbi:10090">transgenic mice</span>
We examined p57Kip2 expression by reverse transcriptase (RT-PCR) and immunohistochemistry in wild type (WT) or single (R26loxpTA-p57k/+) transgenic hearts and compared them to the adult double transgenic (R26loxpTA-p57k/+/Mlc2v-Crek/+) hearts. RT-PCR analysis demonstrated the presence of p57Kip2 message in the adult double transgenic heart, while at the same number of cycles, there was no visible band in the adult WT or single transgenic heart (Figure 1D). The average p57Kip2 expression by quantitative RT-PCR analysis was found to be 2.7 fold higher in compound transgenic hearts (data not shown). Taking into consideration that only 14-20% of adult mouse ventricular cells are cardiomyocytes and the reported success of recombination is approximately 80% with the Mlc2v-Cre mouse [21], this result indicates that the cardiomyocytes of the compound transgenic mice express an 8-12 fold higher level of p57Kip2 transcripts above the wild type control animals [5,21]. Since there may still be some non-ventricular tissue in this preparation, this number represents a lower estimate of the efficiency of our transgenic system at the mRNA level. Immunohistochemistry demonstrated that p57Kip2 is abundantly present in the nuclei of adult cardiomyocytes in the R26loxpTA-p57k/+;Mlc2v-Crek/+ transgenic mice (approximately 80% of the cardiomyocytes nuclei are stained for p57Kip2, whereas it is virtually absent from the cardiomyocytes of wild-type animals (Figure 2). We did not observe p57Kip2 expression in the skeletal muscle or in the liver of the double transgenic animals (Figure 2F, 2G). These results indicate that the transgene is not only specific and effective in overexpressing p57Kip2 in cardiomyocytes, but also that the cellular capacity for degradation of p57Kip2 is overcome and not sufficient to reduce the elevated protein levels to normal.
###end p 19
###begin p 20
###xml 3 8 3 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p57<sup>Kip2 </sup>protein is expressed specifically in the adult transgenic mouse heart</bold>
###xml 82 87 82 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 120 133 120 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 136 146 136 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-Cre</italic>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 155 161 155 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, E)</bold>
###xml 197 203 197 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A, D)</bold>
###xml 208 213 208 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 306 310 306 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 320 323 320 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F)</bold>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
p57Kip2 protein is expressed specifically in the adult transgenic mouse heart. p57Kip2 expressed in the hearts of adult R26loxpTA-p57k/+;Mlc2v-Cre+/- mice (B, E), while it is absent from WT hearts (A, D). p57Kip2 expression is restricted to the hearts of transgenic animals and is absent from adult muscle (C) and liver (F).
###end p 20
###begin p 21
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 23 28 23 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 117 122 117 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 271 276 271 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 356 366 356 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlc2v-Cre </italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 431 436 431 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 466 472 466 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlc2v </italic>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
During development, p57Kip2 gene expression is first observed in the heart of WT mice at E10.5 [14,15]. By E11.5, p57Kip2 protein is present in the nuclei of the endocardial cells and in about 75% of the WT cardiomyocytes (Figure 3). In the double transgenic embryos, p57Kip2 was first detected in cardiomyocyte nuclei at E9.5, following the expression of Mlc2v-Cre during early myocardial differentiation [22], indicating that p57Kip2 expression is directed by the Mlc2v promoter (Figure 3D).
###end p 21
###begin p 22
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 10 15 10 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Forced <italic>p57</italic><sup><italic>Kip</italic>2 </sup>expression in the embryonic heart does not impair cardiomyocyte proliferation</bold>
###xml 113 118 113 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 185 198 185 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 201 211 201 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-Cre</italic>
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 211 215 211 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 284 289 284 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 310 315 310 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-C)</bold>
###xml 329 334 329 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 377 390 377 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 393 403 393 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-Cre</italic>
###xml 403 407 403 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 438 443 438 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D-F)</bold>
###xml 462 467 462 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 530 536 530 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E, F)</bold>
###xml 568 581 568 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 581 584 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 584 594 584 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-Cre</italic>
###xml 594 595 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 594 598 594 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 688 693 688 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1011 1016 1011 1016 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1044 1049 1044 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1111 1120 1111 1120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G, H, I)</bold>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 598 613 <span type="species:ncbi:10090">transgenic mice</span>
Forced p57Kip2 expression in the embryonic heart does not impair cardiomyocyte proliferation. Localization of p57Kip2 and Ki-67 in ventricular cardiomyocytes of E9.5 wild type (WT) and R26loxpTA-p57k/+;Mlc2v-Crek/+ animals by indirect immunofluorescence. In WT E9.5 cardiomyocytes p57Kip2 is not yet expressed (A-C). However, p57Kip2 is expressed in most cardiomyocytes of the R26loxpTA-p57k/+;Mlc2v-Cre+/- mouse embryos as early as E9.5 (D-F). Expression of p57Kip2 in embryonic cardiomyocytes does not preclude Ki-67 expression (E, F). DNA synthesis in the heart of R26loxpTA-p57k/+;Mlc2v-Crek/+ transgenic mice is similar to the hearts of wild type animals despite the abundance of p57Kip2 protein in the cardiomyocytes of the transgenic hearts. In the merged pictures (third column), the yellow nuclei represent cardiomyocytes co-labeled by both antibodies. High power magnification of the same cardiomyocyte labeled with both antibodies, illustrates that although there are many cells stained with both p57Kip2 and Ki-67, in most cells p57Kip2 and Ki-67 immunoreactivity occur in exclusive nuclear domains (G, H, I).
###end p 22
###begin p 23
###xml 122 127 122 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3 </sup>
###xml 319 321 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
###xml 352 355 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3 </sup>
###xml 367 369 361 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-3</sup>
###xml 552 555 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 555 558 549 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 555 560 549 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 742 744 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 838 843 832 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 897 898 891 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 932 937 926 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1056 1061 1050 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1188 1192 1182 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G&#8211;I</xref>
###xml 1359 1364 1353 1358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1434 1439 1428 1433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1525 1527 1519 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1779 1784 1773 1778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
Gross cardiac defects and histological evidence of ventricular thinning, hypertrophy, or fibrosis were absent in adult p57Kip2 overexpressing hearts. Similarly, the ratio of heart weight to body weight (HW/BW) of the transgenic hearts did not significantly differ from that of wild type animals (6.6 x 10-3 +/- 0.2 x 10-3, m +/- SEM, n = 8 vs. 7.5 x 10-3 +/- 0.7 x 10-3, n = 4) at 3 months of age. There was also no difference in the rate of apoptosis at this age as determined by TUNEL assay (data not shown). To assess whether cardiomyocyte-specific p57Kip2 overexpression affects cardiomyocyte proliferation we performed immunofluorescence experiments with Ki-67 antibody, a marker for DNA synthesis and cell cycling in E8.5-E11.5 hearts [23]. We did not detect any difference in the number of Ki-67 positive cardiomyocytes between p57Kip2 overexpressing transgenic and control animals (Figure 3). These results indicate that p57Kip2 overexpression does not affect the ability of cardiomyocytes to enter S-phase. Interestingly, in some of the cells, p57Kip2 and Ki-67 immunoreactivity was present in the same nucleus, although they appeared in mutually exclusive nuclear areas (Figure 3G-I). Such cells were found in both transgenic and control animals and therefore cannot be attributed to a transgene effect. This is in accordance with the pattern of p57Kip2 expression described in trophoblast giant cells, in which BrdU and p57Kip2 co-immunoreactivity could be detected after the cells committed to endoreduplication [24]. Endoreduplication is a process of repeated rounds of DNA synthesis in the absence of mitosis, which occurs in both trophoblast cells and cardiomyocytes and results in the formation of polyploid cells. Thus, it is possible that in cardiomyocytes, p57Kip2 expression and terminal differentiation are not associated with cell cycle exit but rather with endoreduplication.
###end p 23
###begin title 24
###xml 3 8 3 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
p57Kip2 expression in adult cardiomyocytes protects hearts from ischemia/reperfusion injury
###end title 24
###begin p 25
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 393 396 393 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 396 401 396 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1068 1069 1068 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1409 1412 1409 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 1412 1415 1412 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 1412 1417 1412 1417 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 1743 1744 1741 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1752 1753 1750 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 1933 1938 1931 1936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 48 63 <span type="species:ncbi:10090">transgenic mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 481 486 <span type="species:ncbi:10090">mouse</span>
After we characterized histologically the adult transgenic mice and demonstrated no differences in 3 months of age, we proceeded with the analysis of cardiovascular function. We studied age matched adult mice from the same cohort that covered the adult lifespan from 14-30 weeks, when the excitation-coupling mechanisms are known to remain constant [25]. To assess the contractile function of p57Kip2 overexpressing transgenic hearts, we utilized the Langendorff isolated perfused mouse heart preparation as previously described [26-28]. After 30 minutes of stabilization baseline functional data were obtained and the hearts were then subjected to a protocol of 30 minutes global ischemia followed by 30 minutes reperfusion. This protocol is based on our experience from previous studies [26-28]. In one of the experiments we assessed the myocardial necrotic area after staining with 10% 2,3,5-triphenyltetrazolium chloride (TTC) and we found that the area of necrotic tissue was reduced (20% vs. 37%) in the double transgenic heart compared with the control (Figure 4). The baseline functional parameters, including left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LVEDP), LVdp/dt, rate pressure product (RPP) and heart rate (HR) were not significantly different between the different groups. However, after subjecting the hearts to 30 minutes of ischemia, the reperfused p57Kip2 expressing hearts exhibited significantly better preservation of cardiac function than the WT hearts. More specifically the transgenic hearts demonstrated higher left ventricular developed pressure (LVDP), rate pressure product (RPP) and coronary flow (CF) as assessed at the end of the reperfusion period (p </= 0.05, Figure 5; Table 2). The hemodynamic benefits were apparent from the onset of the reperfusion stage and were maintained throughout the 30 min period, suggesting that the protective effect of the p57Kip2 transgene may be manifest during the acute hypoxic phase and not restricted to the reperfusion phase of the injury.
###end p 25
###begin p 26
###xml 3 8 3 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 0 111 0 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p57<sup>Kip2 </sup>protects hearts from ischemia/reperfusion (I/R) injury in the Langendorff isolated perfused heart model</bold>
###xml 224 237 224 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 240 250 240 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-Cre</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 250 254 250 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 444 454 444 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink">(max/min) </sub>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 559 563 559 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
p57Kip2 protects hearts from ischemia/reperfusion (I/R) injury in the Langendorff isolated perfused heart model. Upper Panel: Representative hemodynamic tracings from Langendorff isolated perfused heart from a control and a R26loxpTA-p57k/+;Mlc2v-Crek/+ animal. Real-time condensed recordings of hemodynamic parameters (LVP=left ventricular pressure, LVSP=left ventricular systolic pressure, LVEDP=left ventricular end diastolic pressure, dp/dt(max/min) and HR) are shown. Lower Panel: Representative sections of a control (left) and a R26loxpTA-p57k/+;Mlc-2v+/- (right) heart. The hearts were sliced into sections and stained with 2,3,5-TTC followed by formalin fixation. Viable tissue is stained brick red, while infarcted areas are white. Note the more significant necrotic area (black arrow) in the injured, control heart.
###end p 26
###begin p 27
###xml 91 96 91 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 117 130 117 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 133 143 133 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc-2vCre</italic>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 0 196 0 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Summary of hemodynamic data from the isolated heart perfusion evaluation of control and p57<sup>Kip2 </sup>overexpressing mice (<italic>R26loxpTA-p57</italic><sup><italic>k</italic>/+</sup><italic>;Mlc-2vCre</italic><sup><italic>k</italic>/+</sup>), at baseline and post ischemia/reperfusion (I/R)</bold>
###xml 387 397 387 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink">(max/min) </sub>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Summary of hemodynamic data from the isolated heart perfusion evaluation of control and p57Kip2 overexpressing mice (R26loxpTA-p57k/+;Mlc-2vCrek/+), at baseline and post ischemia/reperfusion (I/R). Left Ventricular Systolic Pressure (LVSP), Left Ventricular End Diastolic Pressure (LVEDP), Left Ventricular Developed Pressure (LVDP), Heart Rate (HR), Rate Pressure Product (RPP), LVdp/dt(max/min) and Coronary Flow (CF). LVDP, RPP and CF were better conserved in the transgenic hearts to a statistical significant degree compared to the hearts of wild type littermates (p < 0.05).
###end p 27
###begin p 28
Description of experimental animals and cardiac functional parameters
###end p 28
###begin p 29
###xml 123 129 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t-test</italic>
###xml 218 234 216 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fisher post hoc </italic>
Values are means +/- SE. The two asterisks (**) indicate statistical significance with a probability of p < 0.05 (unpaired t-test), while the one asterisk indicates a probability of p = 0.05. One-way ANOVA followed by Fisher post hoc test also indicated significant difference among these groups. There was also a strong trend for lower LVEDP in the transgenic hearts; however with the small number of tested animals this did not reach statistical significance. LVSP, left ventricular systolic pressure; LVEDP, left ventricular end diastolic pressure; LVDP, left ventricular developed pressure, HR, heart rate; RPP, rate pressure product; CF, coronary flow.
###end p 29
###begin title 30
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
p57Kip2-mediated cardioprotection in the ex vivo ischemia reperfusion injury is associated with modulation of the stress signaling cascade
###end title 30
###begin p 31
###xml 9 14 9 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 138 143 138 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 434 439 434 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 607 608 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 723 728 723 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
Since p57Kip2 has been found to physically interact with and inhibit JNK/SAPK, we investigated whether the cardioprotective effects of p57Kip2 were mediated through modulation of the JNK stress signaling pathway. We performed a phospho-proteomic screen that demonstrated wide ranging changes in the stress signaling cascade. These included a 28-34% reduction in phosphorylation of the JNK/SAPK epitopes Y185 and T183 from ischemic p57Kip2 overexpressing hearts compared to similarly ischemic control hearts after normalization to control for inaccuracies in protein determination and sample loading (Figure 6). In addition, phosphorylation changes in other stress signaling molecules not known to be directly related to p57Kip2 such as alphaB-crystallin and heat shock protein 27 (Hsp27), MEK1, MARCKS, Akt1, PKCdelta and PKCgamma were also found in this screen.
###end p 31
###begin p 32
###xml 3 7 3 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 0 139 0 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p57<sup>Kip2</sup>-mediated cardioprotection in the <italic>ex vivo </italic>ischemia-reperfusion injury is associated with modulation of the stress signaling response</bold>
###xml 289 296 289 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kinexus</italic>
###xml 296 299 296 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tm </italic>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Tm </italic></sup>
p57Kip2-mediated cardioprotection in the ex vivo ischemia-reperfusion injury is associated with modulation of the stress signaling response. Phospho-site screen analysis of key stress signaling molecules was performed by standardized densitometric quantification of Western immunoblots by KinexusTm Bioinformatics Corporation (Vancouver, Canada). The graph includes stress signaling molecules that display a significant difference between transgenic and control hearts.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 3 8 3 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 133 138 133 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 319 324 319 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 406 411 406 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 477 482 477 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 681 685 681 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 740 753 740 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 753 754 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 753 756 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 756 766 756 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">;Mlc2v-Cre</italic>
###xml 766 767 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 766 770 766 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 912 917 912 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1013 1018 1013 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1111 1116 1111 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1368 1372 1368 1372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 1399 1404 1399 1404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1512 1514 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1548 1553 1548 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1710 1715 1710 1715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1833 1838 1833 1838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1925 1930 1925 1930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 2076 2078 2076 2078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 770 785 <span type="species:ncbi:10090">transgenic mice</span>
p57Kip2 encodes a maternally expressed cyclin dependent kinase inhibitor of the CIP/KIP family. While loss of function studies on p57Kip2 have provided important functional clues, herein we report over-expression experiments that provide additional insight into its function. For better understanding of the role of p57Kip2 in the cardiac tissue, we created a transgenic model that forces expression of p57Kip2 beyond its narrow temporal window of expression. In our model, p57Kip2 expression was observed from early gestation (E9.5) and the tissue-specific pattern persisted into adult life at 2.7 fold higher levels over the wild type controls. Cardiac specific expression of p57Kip2beginning at E9.5 did not appear to be deleterious, as R26loxpTA-p57k/+;Mlc2v-Crek/+ transgenic mice displayed normal cardiac growth both during development and postnatal life. This is in contrast to the observed effects of p57Kip2 on other tissues, such as kidney and brain, that were shown to be sensitive to an even lower p57Kip2 dosage change in BAC transgenic animals [29]. In addition, DNA synthesis persisted in the p57Kip2 over-expressing cardiomyocytes, suggesting that the ability of cardiomyocytes to enter S-phase remained unimpaired. It is likely that sufficient amounts of the necessary CDKs are present in the fetal cardiomyocytes to overcome the induced excess of p57Kip2. Alternatively, excess p57Kip2 could also have been removed by ubiquitination of the QT domain and degraded via the proteasome pathway [30,31]. However, the widely present p57Kip2 protein in the fetal and adult cardiomyocytes, beyond the spatial and temporal pattern of endogenous expression, indicates that the cellular capacity for p57Kip2 degradation was overcome and not sufficient to normalize the elevated protein levels. The concurrent expression of p57Kip2 in actively proliferating cells is intriguing and suggests that, in cardiomyocytes, p57Kip2 expression and terminal differentiation are not necessarily associated with cell cycle exit but rather with endoreduplication as in trophoblasts [24].
###end p 34
###begin p 35
###xml 54 59 54 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 249 254 249 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 580 585 580 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 933 938 933 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1050 1055 1050 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1197 1202 1197 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1226 1231 1226 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1458 1460 1458 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1604 1606 1604 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1767 1772 1767 1772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 2204 2213 2196 2205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 2217 2225 2209 2217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2241 2243 2233 2235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 2244 2246 2236 2238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 2382 2386 2374 2378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</sup>
###xml 2510 2515 2502 2507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1217 1221 <span type="species:ncbi:10090">mice</span>
###xml 1391 1396 <span type="species:ncbi:9606">human</span>
In our studies, we found that forced expression of p57Kip2 in the adult heart was associated with a protective effect when the heart undergoes injury by transient ischemia/reperfusion. It seems unlikely that the cell cycle inhibitory function of p57Kip2 is a factor in this process, as the protective effect was immediate. An alternative explanation to consider is the improved coronary flow in the transgenic hearts. Ischemia and reperfusion significantly increase tissue edema in the injured myocardium with secondary compromise of the regional coronary flow [32]. Since the p57Kip2 transgene expression is restricted in cardiomyocytes and not present in smooth muscle or endothelial cells, we believe that the preservation of coronary flow is rather secondary to the decreased tissue edema in the transgenic hearts than a primary improvement in coronary vascular flow. Instead, it is more plausible that a separate function of p57Kip2 leads to cardiac protection in the hypoxic phase of I/R injury. Our experiments support the possibility that p57Kip2 modulates the stress signaling response after ischemia-reperfusion challenge. For example, we observed lower levels of JNK activity in the p57Kip2 overexpressing mice. p57Kip2 was shown to modulate stress-activated signaling and apoptosis by inhibiting c-Jun amino-terminal kinase/stress-activated protein kinase (JNK/SAPK) in cultured human embryonic kidney cells, embryonic fibroblasts and myoblasts [17]. JNK is activated following ischemia/reperfusion injury, and when the kinase activity is repressed, the area of infarct damage is diminished [33]. However, phosphorylation alterations were not restricted to the JNK/MAPK but involved other stress signaling molecules not known to be directly related to p57Kip2 such as crystalline aB and heat shock protein 27 (Hsp27), MEK1, MARCKS, Akt1, PKCdelta and PKCgamma. While activation of some of these proteins is reported to be protective in cardiac disease (heat shock proteins), genetic and pharmacologic manipulation of some others such as JNK/MAPK, Akt1 and PKC has been reported to have conflicting or unknown roles, with both protective and detrimental ramifications for cardiomyocytes after in vitro and in vivo hypoxic injury [34-39]. Although, the mechanism for these phosphorylation changes is not known at this point, these data support the possibility that the p57Kip2-mediated cardioprotection is associated with wide changes of the stress signaling cascade. These findings indicate that p57Kip2 protein may be a converging point for the regulation of cellular stress, cell proliferation and apoptosis.
###end p 35
###begin p 36
###xml 139 143 139 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Cip1</sup>
###xml 150 155 150 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip1 </sup>
###xml 173 178 173 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 356 361 356 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 551 554 551 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 551 556 551 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 720 725 720 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 978 983 978 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1096 1101 1096 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 1177 1182 1177 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
###xml 1256 1261 <span type="species:ncbi:10090">mouse</span>
Studies from human patients with both acute and end-stage heart failure reveal that CKIs revert to a fetal pattern of expression, i.e., p21Cip1and p27Kip1 decline, while p57Kip2 is significantly increased [16]. In addition, a recent analysis of the transcriptional regulation of the human proximal tubular epithelial cell response to hypoxia identified p57Kip2 among a tightly regulated cluster of 48 genes that demonstrated time-dependent up-regulation in response to hypoxia and a distinct down-regulation upon reoxygenation [18]. Significantly, p57Kip2 was up-regulated at early time points of hypoxia indicating it was within the early wave of hypoxia-responsive genes rather than being secondarily induced [18]. p57Kip2 is normally highly expressed in the heart during midgestation, a time when the coronary arteries are not yet connected to the aortic root and the fetal heart grows in a low oxygen tension environment. These observations suggest a protective role for p57Kip2 under conditions of limited oxygen supply. Our results provide additional support for this protective role of p57Kip2 in the setting of hypoxia by demonstrating that persistent expression of p57Kip2 in cardiomyocytes attenuates the ischemia-reperfusion injury in the adult mouse heart.
###end p 36
###begin p 37
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 3 6 3 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 3 8 3 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax3 </italic>
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Splotch</italic>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bmp10 </italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 552 555 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 555 560 555 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 606 609 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 609 612 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 609 614 609 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 844 847 844 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 847 850 847 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 847 852 847 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 953 958 953 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 574 579 <span type="species:ncbi:10090">mouse</span>
p57Kip2 over-expression has been reported by us and other investigators in two independent mouse models of thin myocardium, one resulting from mutation of the Pax3 transcription factor (Splotch) [14] and the other from deletion of the secreted factor Bmp10 [40]. This phenotype was associated with a reduction in cardiomyocyte proliferative activity, while there was no evidence of increased apoptosis. These findings are consistent with early suppression of cardiomyocyte replication and increased differentiation associated with enhanced activity of p57Kip2 in the mutant mouse hearts. The mechanism for p57Kip2 up-regulation in these two models remains unknown, but given the different nature of their genetic defects, a direct transcriptional regulation is unlikely to be involved. An alternative explanation for this finding could be that p57Kip2 up-regulation represents a secondary, adaptation type of response, or a selective survival of the p57Kip2 expressing cardiomyocytes under conditions of increased stress imposed on the developmentally impaired thin myocardial wall.
###end p 37
###begin title 38
Conclusion
###end title 38
###begin p 39
###xml 85 88 85 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 88 93 88 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 140 145 140 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 273 278 273 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 563 566 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 563 568 563 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 778 783 778 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 291 296 <span type="species:ncbi:10090">mouse</span>
We have generated a transgenic mouse model that allows specific forced expression of p57Kip2 in cardiomyocytes. The forced expression of p57Kip2 in cardiomyocytes did not affect heart development, growth or baseline cardiac function. However, the continuous presence of p57Kip2 in the adult mouse heart results in resistance to myocardial ischemia/reperfusion injury and improved recovery of cardiac function. Preservation of myocardiac function after ischemia/reperfusion depends on critical adaptive responses of the stress signaling network. In the case of p57Kip2 overexpression, the exact mechanism of this cardioprotection has not been fully elucidated, but it was associated with wide range modulations of proteins in stress signaling pathways. It is conceivable that p57Kip2 is part of the pre-conditioning process that protects the myocardium from ischemia-reperfusion injury and may constitute a new therapeutic target for ischemic cardiac disease.
###end p 39
###begin p 40
###xml 63 68 63 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 586 589 586 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 589 592 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 589 594 589 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
As hypoxic stress contributes to many biological disorders, p57Kip2 may be of general physiological importance for controlling cell proliferation and death under conditions of limited oxygen availability during embryonic cardiac development and pathologic ischemic conditions of adulthood. Comparison of the physiological state of embryonic development with pathologic conditions of cardiac stress in adulthood, suggests that in adult cardiomyocytes, the genetic response to stress is to revert to the expression of fetal genetic patterns associated with embryonic cardiac development. p57Kip2 appears to be one of these fetal genes, which re-emerges under conditions of hypoxic/ischemic stress. Thus, the hypoxic developmental history may provide a useful insight in the adult heart's genetic response to ischemia, by the redeployment of genes that were adapted to the low oxygen tension characteristic of the fetal/embryonic environment.
###end p 40
###begin title 41
Methods
###end title 41
###begin title 42
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 42
###begin p 43
###xml 73 82 73 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pROSA26PA</italic>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 159 162 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 159 164 159 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 222 228 222 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pBigT </italic>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 354 364 354 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pROSA26PA </italic>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 427 441 427 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxp-TAp57 </italic>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 457 471 457 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxp-TAp57 </italic>
###xml 671 680 671 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26FL </italic>
###xml 707 711 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-3' </italic>
###xml 715 726 715 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA26SA 5'</italic>
###xml 727 754 727 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CATCAAGGAAACCCTGGACTACTG-3'</italic>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 509 514 <span type="species:ncbi:10090">mouse</span>
A gene-targeting vector was constructed using a ROSA26 targeting vector (pROSA26PA) [41]. A 1.4 kb cDNA containing the complete open reading frame of mouse p57Kip2 (generously provided by S. Elledge) was inserted into the pBigT vector [41] downstream to a loxP-flanked transcriptional termination sequence (tpA). This fragment was then inserted into the pROSA26PA plasmid [41,42] to create the targeting vector, now designated R26loxp-TAp57 (Figure 1). The R26loxp-TAp57 plasmid was electroporated into AB2.2 mouse embryonic stem (ES) cells and successful homologous recombination was determined by PCR analysis and confirmed by Southern blotting. The primers used were: ROSA26FL 5'-CCTAAAGAAGAGGCTGTGCTTTGG-3' and ROSA26SA 5'-CATCAAGGAAACCCTGGACTACTG-3'.
###end p 43
###begin p 44
###xml 13 27 13 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxp-TAp57 </italic>
###xml 77 83 77 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c-Brd </sup>
###xml 215 221 215 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c-Brd </sup>
###xml 381 394 381 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 394 395 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+</sup>
###xml 399 412 399 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26loxpTA-p57</italic>
###xml 412 413 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">k</italic>
###xml 412 416 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>k</italic>/+ </sup>
###xml 463 479 463 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre-recombinase </italic>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlc2v </italic>
###xml 620 623 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 623 626 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 623 627 623 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2</sup>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 516 521 <span type="species:ncbi:10090">mouse</span>
###xml 629 633 <span type="species:ncbi:10090">Mice</span>
Two separate R26loxp-TAp57 harboring ES clones were injected into C57BL/6-Tyrc-Brd blastocysts and implanted into pseudo-pregnant females for the generation of chimeras. The male chimeras were mated with C57BL/6-Tyrc-Brd to obtain F1 progeny. Eight animals with germline transmitted alleles were derived from two independently targeted ES cell lines. These mice were designated as R26loxpTA-p57k/+. R26loxpTA-p57k/+ mice were bred with knock-in mice carrying the Cre-recombinase gene under control of the endogenous mouse Mlc2v promoter (generously provided by J. Chen, UCSD) to induce myocardial specific expression of p57Kip2. Mice were bred on a mixed C57BL/6 or 129/Sv background and were genotyped using tail extracted genomic DNA for diagnostic PCR amplification (Figure 1C).
###end p 44
###begin p 45
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSA </italic>
###xml 239 283 239 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSAFORW 5'-CTCCTCAGAGAGCCTCGGCTAGGTAGGGGATC</italic>
###xml 291 336 291 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ROSAREV 5'-GGGCGTTGTCCTGCAGGGGAATTGAACAGGTG-3</italic>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip</italic>
###xml 354 359 354 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip</italic>2 </sup>
###xml 513 519 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LA Taq</italic>
###xml 546 562 537 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAKARA Mirus Inc</italic>
###xml 774 778 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cre </italic>
###xml 832 869 799 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CREFORW 5'-GTTCGCAAGAACCTGATGGACA-3' </italic>
###xml 873 908 840 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CREREV 5'-CTAGAGCCTGTTTTGCACGTTC-3'</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were evaluated by genomic DNA analysis at 3 weeks and at the time of their sacrifice (14-18 weeks). To detect the various alleles (ROSA wild-type:1.2 kb, transgenic: 6 Kb, or recombinant transgenic allele: 3.3 kb) we used the primers ROSAFORW 5'-CTCCTCAGAGAGCCTCGGCTAGGTAGGGGATC-3' and ROSAREV 5'-GGGCGTTGTCCTGCAGGGGAATTGAACAGGTG-3. The inserted p57Kip2 was not expressed unless cre-mediated recombination removed the transcriptional termination sequence. A proofreading Taq polymerase for long transcripts (LA Taqtrade mark DNA Polymerase, TAKARA Mirus Inc, Japan) was used with the following PCR protocol: 94degreesC for 1 min, followed by 30 cycles of 94degreesC for 30 sec and annealing/extension at 67degreesC for 6 min and 10 minutes extension at 72degreesC. The cre allele (300 bp) was detected by PCR using the primers CREFORW 5'-GTTCGCAAGAACCTGATGGACA-3' and CREREV 5'-CTAGAGCCTGTTTTGCACGTTC-3'.
###end p 45
###begin p 46
Experiments were performed according to guidelines from the National Institutes of Health and with an approved protocol from the Animal Care and Use Committee.
###end p 46
###begin title 47
Histological analysis
###end title 47
###begin p 48
###xml 164 169 163 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Kip2 </sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 438 444 <span type="species:ncbi:9986">rabbit</span>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
###xml 689 695 <span type="species:ncbi:9986">rabbit</span>
Mouse tissues and embryos were fixed with 2% PFA overnight, dehydrated, embedded in paraffin, and sectioned at 5 mum thickness. Primary antibodies included anti-p57Kip2 (Ab-4058, Abcam inc. Cambridge, MA; H-91, Santa Cruz BioTechnologies, Santa Cruz, CA) at 1:50, Ki-67 (550609, BD Pharmingen, San Jose, CA) at 1:50, and anti-MHC (MF-20, from DHSB, University of Iowa) at 1:150. Secondary detection occurred by fluorescence with the anti-rabbit Cy3 (Jackson Immunoresearch, West Grove, PA) or anti-mouse Alexa 488 (Molecular Probes, Eugene, OR) at 1:200 and mounted in media containing DAPI (Vectashield, Vector Laboratories, Burlingame, CA). For immunohistochemistry, a biotinylated anti-rabbit antibody was used at 1:200 and developed using the ABC-DAB system (Vector Laboratories). Slides were counterstained with Methylene Blue and mounted in Permount.
###end p 48
###begin title 49
RT-PCR
###end title 49
###begin p 50
Total RNA was isolated from control and mutant adult hearts by Trizol (Invitrogen, Carlsbad, CA) extraction. The PCR reactions were performed with the 7500 RT-PCR system (Applied Biosystems, Foster City, CA) using Brilliant SYBR Green QRT-PCR Master Mix (Stratagene, La Jolla, CA) and the housekeeping gene beta-actin for internal normalization. All samples were tested in triplicates for each genotype and the results represent averages of individual experiments.
###end p 50
###begin title 51
Langendorff isolated perfused heart and assessment of cardiac function
###end title 51
###begin p 52
###xml 220 222 220 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 231 233 231 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 394 396 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1386 1393 1366 1373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max/min</sub>
###xml 1604 1605 1584 1585 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
Adult male mice (14-30 weeks) were euthanized with an intraperitoneal injection of pentobarbital sodium. Hearts were rapidly excised and arrested in ice-cold Krebs-Henseleit buffer, which was constantly gassed with 95% O2 and 5% CO2 to give a pH of 7.4 at 37degreesC. The buffer was perfused at a constant pressure of 55 mm Hg in the non-recirculating Langendorff mode as previously described [28]. Briefly, the hearts were cannulated via the ascending aorta for retrograde perfusion. A left atrial incision was made to expose the mitral annulus, through which a water-filled latex balloon was passed into the LV. The balloon was attached to a pressure transducer, which was connected to an A/D Converter. The converter transmits the data to a computer running a cardiovascular data acquisition software and recording system (Biopac, MP 100). The LV balloon was inflated to adjust the LV end-diastolic pressure (LVEDP) to approximately 10 mm Hg. Myocardial function was measured at multiple, independent end points. The following functional parameters were monitored and constantly recorded: left ventricular developed pressure (LVDP), which is the difference of left ventricular end systolic pressure (LVESP) minus left ventricular end-diastolic pressure (LVEDP), heart rate, coronary flow (CF), the maximum positive or negative first derivative of left ventricular pressure (+/- dP/dtmax/min) (as index of inotropic and relaxation state respectively), and the rate pressure product (RPP=LVDPXHR) was calculated and used as index of cardiac work and indirect measure of myocardial oxygen utilization (VO2).
###end p 52
###begin title 53
Protein extraction and phospho-proteomic screen
###end title 53
###begin p 54
###xml 128 136 128 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex-vivo </italic>
###xml 167 169 167 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 40 55 <span type="species:ncbi:10090">transgenic mice</span>
Hearts (two from wild type and two from transgenic mice) were collected after baseline evaluation or after ischemia-reperfusion ex-vivo injury, snap-frozen in liquid N2 and stored at -80degreesC. The frozen hearts were washed with ice-cold PBS and cut into small pieces in protein lysis buffer containing 0.5% Triton X-100 and proteinase inhibitors. Cardiac tissue lysates were prepared by homogenization and sonication with a Brickmann Polytron homogenizer and a Fisher Sonic Dismembrator. Protein concentrations were determined with the bicinchoninic acid assay (BCAtrade mark Protein Assay kit, Pierce, Rockford, IL). The phospho-proteomic screen was performed and analyzed by Kinexus Inc. (Vancouver, Canada).
###end p 54
###begin title 55
Statistical analysis
###end title 55
###begin p 56
###xml 385 401 383 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fisher post hoc </italic>
###xml 520 523 518 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
For parameters that require quantification and evaluation for statistical significance, results were expressed as mean +/- standard error of the mean (SEM). Statistical significance (probability values) was determined using the student's t-test (two tailed distribution and two sample unequal variance). For multiple group comparisons, one way analysis of variance (ANOVA) followed by Fisher post hoc test was used. A probability of p = 0.05 was considered to represent statistical significance. Differences in observed vs expected numbers of a particular genotype were determined using the Chi-squared test.
###end p 56
###begin title 57
Abbreviations
###end title 57
###begin p 58
CDK, cyclin dependent kinase; CKI, cyclin dependent kinase inhibitor; CF, coronary flow; RPP, rate pressure product; LVDP, left ventricular developed pressure; LVEDP, left ventricular end-diastolic pressure; LVESP, left ventricular end systolic pressure
###end p 58
###begin title 59
Authors' contributions
###end title 59
###begin p 60
SAH: created the targeting construct, performed the molecular studies and drafted the manuscript.
###end p 60
###begin p 61
TZ: performed the cardiac function experiments with the Langendorff isolated perfused heart system and analyzed their results.
###end p 61
###begin p 62
LJ: extracted protein and performed immunoassays, managed the animal colony including genotyping, and coordinated the experimental progress.
###end p 62
###begin p 63
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 79 94 <span type="species:ncbi:10090">transgenic mice</span>
JAK: performed and supervised the mouse ES cell work and the generation of the transgenic mice as Director of the Animal Transgenic Facility at Brown University.
###end p 63
###begin p 64
JFP: participated in the design and coordination of the study and critically reviewed the manuscript.
###end p 64
###begin p 65
LKK: conceived and designed the study, interpreted the results, coordinated the experiments, helped to draft the manuscript and critically reviewed and revised its final version.
###end p 65
###begin p 66
All authors read and approved the final manuscript.
###end p 66
###begin title 67
Acknowledgements
###end title 67
###begin p 68
The CT3 antibody developed by C.C.-J. Lin and the MF20 antibody developed by D.A. Fischman were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242. We appreciated fruitful discussions and feedback from Dr. James Cross, University of Calgary. This work was supported by the NIH grants P20RR018728 (S.A.H., T.C.Z., L.Z., J.F.P, and L.K.K.) and P20RR015578-06 (J.E.K.).
###end p 68
###begin article-title 69
Sizing up the heart: development redux in disease
###end article-title 69
###begin article-title 70
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha
###end article-title 70
###begin article-title 71
Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1
###end article-title 71
###begin article-title 72
Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development
###end article-title 72
###begin article-title 73
###xml 52 58 <span type="species:ncbi:10090">murine</span>
Cardiomyocyte DNA synthesis and binucleation during murine development
###end article-title 73
###begin article-title 74
CDK inhibitors: positive and negative regulators of G1-phase progression
###end article-title 74
###begin article-title 75
Cell-cycle inhibitors: three families united by a common cause
###end article-title 75
###begin article-title 76
Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors
###end article-title 76
###begin article-title 77
Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development
###end article-title 77
###begin article-title 78
Cardiomyocyte cell cycle regulation
###end article-title 78
###begin article-title 79
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation
###end article-title 79
###begin article-title 80
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development
###end article-title 80
###begin article-title 81
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome
###end article-title 81
###begin article-title 82
###xml 50 56 <span type="species:ncbi:10090">murine</span>
p57Kip2 expression is enhanced during mid-cardiac murine development and is restricted to trabecular myocardium
###end article-title 82
###begin article-title 83
Dynamic temporal and spatial regulation of the cdk inhibitor p57(kip2) during embryo morphogenesis
###end article-title 83
###begin article-title 84
###xml 48 53 <span type="species:ncbi:9606">human</span>
Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development
###end article-title 84
###begin article-title 85
p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase
###end article-title 85
###begin article-title 86
The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia
###end article-title 86
###begin article-title 87
Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes
###end article-title 87
###begin article-title 88
Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy
###end article-title 88
###begin article-title 89
Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis
###end article-title 89
###begin article-title 90
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Sodium-calcium exchanger is initially expressed in a heart-restricted pattern within the early mouse embryo
###end article-title 90
###begin article-title 91
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 37 40 <span type="species:ncbi:10116">rat</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
Formation of human myocardium in the rat heart from human embryonic stem cells
###end article-title 91
###begin article-title 92
Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle
###end article-title 92
###begin article-title 93
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging
###end article-title 93
###begin article-title 94
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart
###end article-title 94
###begin article-title 95
###xml 150 154 <span type="species:ncbi:10090">mice</span>
Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice
###end article-title 95
###begin article-title 96
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Protein kinase C-delta mediates adenosine A3 receptor-induced delayed cardioprotection in mouse
###end article-title 96
###begin article-title 97
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7
###end article-title 97
###begin article-title 98
Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation
###end article-title 98
###begin article-title 99
Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site
###end article-title 99
###begin article-title 100
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning
###end article-title 100
###begin article-title 101
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
###end article-title 101
###begin article-title 102
Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo
###end article-title 102
###begin article-title 103
Akt1 in the cardiovascular system: friend or foe?
###end article-title 103
###begin article-title 104
Cardiac adaptation to ischemia-reperfusion injury
###end article-title 104
###begin article-title 105
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
Roles for alphaB-crystallin and HSPB2 in protecting the myocardium from ischemia-reperfusion-induced damage in a KO mouse model
###end article-title 105
###begin article-title 106
Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion
###end article-title 106
###begin article-title 107
Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury
###end article-title 107
###begin article-title 108
###xml 57 63 <span type="species:ncbi:10090">murine</span>
BMP10 is essential for maintaining cardiac growth during murine cardiogenesis
###end article-title 108
###begin article-title 109
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
###end article-title 109
###begin article-title 110
Generalized lacZ expression with the ROSA26 Cre reporter strain
###end article-title 110

